Dr. Prasad Deepak Dandekar

@mitbio.edu.in

School of Bioengineering Sciences and Research, MITADT University
Assistant Professor



                    

https://researchid.co/prasaddand

RESEARCH INTERESTS

Antidiabetics, Antiviral Drugs, Phytochemistry

2

Scopus Publications

26

Scholar Citations

2

Scholar h-index

1

Scholar i10-index

Scopus Publications

  • Insights into the Inhibition Mechanism of Human Pancreatic α-Amylase, a Type 2 Diabetes Target, by Dehydrodieugenol B Isolated from Ocimum tenuiflorum
    Prasad D. Dandekar, Amol S. Kotmale, Shrawan R. Chavan, Pranita P. Kadlag, Sangeeta V. Sawant, Dilip D. Dhavale, and Ameeta RaviKumar

    American Chemical Society (ACS)
    Use of human pancreatic α-amylase (HPA) inhibitors is one of the effective antidiabetic strategies to lower postprandial hyperglycemia via reduction in the dietary starch hydrolysis rate. Many natural products from plants are being studied for their HPA inhibitory activity. The present study describes isolation of dehydrodieugenol B (DDEB) from Ocimum tenuiflorum leaves using sequential solvent extraction, structure determination by one-dimensional (1D) and two-dimensional (2D) NMR analyses, and characterization as an HPA inhibitor using kinetics, binding thermodynamics, and molecular docking. DDEB uncompetitively inhibited HPA with an IC50 value of 29.6 μM for starch and apparent Ki′ of 2.49 and Ki of 47.6 μM for starch and maltopentaose as substrates, respectively. The circular dichroism (CD) study indicated structural changes in HPA on inhibitor binding. Isothermal titration calorimetry (ITC) revealed thermodynamically favorable binding (ΔG of −7.79 kcal mol–1) with a dissociation constant (Kd) of 1.97 μM and calculated association constant (Ka) of 0.507 μM. Molecular docking showed stable HPA–inhibitor binding involving H-bonds and Pi-alkyl, alkyl–alkyl, and van der Waals (vDW) interactions. The computational docking results support the noncompetitive nature of DDEB binding. The present study could be helpful for exploration of the molecule as a potential antidiabetic drug candidate to control postprandial hyperglycemia.


RECENT SCHOLAR PUBLICATIONS

  • GLYCOSIDASE INHIBITOR, PROCESS FOR ITS PREPARATION, AND APPLICATIONS THEREOF
    AR Prasad Deepak Dandekar
    IN Patent App. 201921036657 A 2021

  • Insights into the Inhibition Mechanism of Human Pancreatic α-Amylase, a Type 2 Diabetes Target, by Dehydrodieugenol B Isolated from Ocimum tenuiflorum
    PD Dandekar, AS Kotmale, SR Chavan, PP Kadlag, SV Sawant, ...
    ACS omega 6 (3), 1780-1786 2021

  • Structure–activity relationships of pancreatic α-amylase and α-glucosidase as antidiabetic targets
    P Dandekar, S Ramkumar, A RaviKumar
    Studies in Natural Products Chemistry 70, 381-410 2021

  • Characterization and Mode of Inhibition of Pancreatic a Amylase Inhibitors Isolated from Medicinal Plants as a Source of Anti Diabetic Agents
    PD Dandekar
    Pune

MOST CITED SCHOLAR PUBLICATIONS

  • Insights into the Inhibition Mechanism of Human Pancreatic α-Amylase, a Type 2 Diabetes Target, by Dehydrodieugenol B Isolated from Ocimum tenuiflorum
    PD Dandekar, AS Kotmale, SR Chavan, PP Kadlag, SV Sawant, ...
    ACS omega 6 (3), 1780-1786 2021
    Citations: 20

  • Structure–activity relationships of pancreatic α-amylase and α-glucosidase as antidiabetic targets
    P Dandekar, S Ramkumar, A RaviKumar
    Studies in Natural Products Chemistry 70, 381-410 2021
    Citations: 6